First Trust Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

First Trust Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-23,984	Closed	-$171K	–	2509
2020 Q1	$171K	Sell	23,984 -12,835	-35%	-$160K	﹤0.01%	2232
2019 Q4	$879K	Buy	36,819 +9,493	+35%	+$262K	﹤0.01%	1930
2019 Q3	$733K	Sell	27,326 -87,292	-76%	-$2.45M	﹤0.01%	1988
2019 Q2	$3.11M	Buy	+114,618	New	+$3.59M	0.01%	1317
2018 Q1	–	Sell	-42,845	Closed	-$2.09M	–	2425
2017 Q4	$2.09M	Sell	42,845 -414	-1%	-$20.9K	0.01%	1503
2017 Q3	$2.34M	Sell	43,259 -27,599	-39%	-$1.62M	0.01%	1365
2017 Q2	$3.98M	Buy	70,858 +54,248	+327%	+$2.17M	0.01%	1110
2017 Q1	$651K	Buy	+16,610	New	+$529K	﹤0.01%	1981

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

First Trust Advisors's PTLA Position: Q2 2020 in Review

First Trust Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 23,984 shares — an estimated $171K sold.

First Trust Advisors first reported a position in PTLA in Q1 2017 and held it in 8 quarters. The position peaked at $3.98M in Q2 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

First Trust Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
First Trust Advisors sold 23,984 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $171K.
First Trust Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and held it in 8 quarters.
First Trust Advisors's Portola Pharmaceuticals, Inc. position peaked at $3.98M in Q2 2017.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on First Trust Advisors's 13F filing for Q2 2020, filed 22 Jul 2020.